NCT00022035View on ClinicalTrials.gov

Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia

NACompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2000

Primary Completion Date

November 30, 2002

Conditions
InfectionLeukemia
Interventions
BIOLOGICAL

trivalent influenza vaccine

Trial Locations (2)

07601

Hackensack University Medical Center, Hackensack

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Roswell Park Cancer Institute

OTHER

NCT00022035 - Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter